● Recruiting

Real-world Secukinumab Outcomes in Canadian HS Patients

Condition: Hidradenitis Suppurativa · Sponsor: Novartis Pharmaceuticals

PhaseN/A

Planned participants142

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

The HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients diagnosed with moderate-to- severe HS who are prescribed secukinumab in Canadian routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com

Novartis Pharmaceuticals · novartis.email@novartis.com

Always discuss trial participation with your own doctor first.

Locations (15)

Novartis Investigative Site	Calgary, Alberta, Canada	Recruiting
Novartis Investigative Site	Calgary, Alberta, Canada	Recruiting
Novartis Investigative Site	Winnipeg, Manitoba, Canada	Recruiting
Novartis Investigative Site	Fredericton, New Brunswick, Canada	Recruiting
Novartis Investigative Site	St. John's, Newfoundland and Labrador, Canada	Recruiting
Novartis Investigative Site	Cobourg, Ontario, Canada	Recruiting
Novartis Investigative Site	Hamilton, Ontario, Canada	Recruiting
Novartis Investigative Site	London, Ontario, Canada	Recruiting
Novartis Investigative Site	Markham, Ontario, Canada	Recruiting
Novartis Investigative Site	Mississauga, Ontario, Canada	Recruiting
Novartis Investigative Site	Richmond Hill, Ontario, Canada	Recruiting
Novartis Investigative Site	Toronto, Ontario, Canada	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07282015